论文部分内容阅读
慢性阻塞性肺病(COPD)是一种以气流受限为特征的常见病,其病情加重期的主要诱因是感染,研究表明抗感染治疗在COPD急性加重期的1型和2型(按Arthonisen标准)有很好的效果,但随着抗生素的广泛使用,有的甚至滥用,耐药菌株不断出现,给治疗COPD的治疗带来困难。就近年来国内外关于COPD急性发作的细菌耐药性研究情况总结如下。
Chronic Obstructive Pulmonary Disease (COPD) is a common disease characterized by limited air flow, and its leading cause of exacerbation is infection. Studies have shown that anti-infective treatment is in Type 1 and 2 acute exacerbation of COPD (according to Arthonisen criteria ) Has a good effect, but with the widespread use of antibiotics, some even abuse, resistant strains continue to appear, the treatment of COPD difficult. In recent years, domestic and international research on bacterial resistance to acute exacerbation of COPD are summarized as follows.